Is Alumis Inc. (ALMS) a Buy, Sell, or Hold?
Alumis Inc.
NASDAQ:ALMS
$28.165 USD
$0.89 (3.24%)
- Volume
- 758.05K
- Average Volume
- 1.35M
- Market Capitalization
- $3.48B
- P/E Ratio
- -14.75
- Dividend Yield
- 0.00%
- Price Target
- $39.00
- Year High
- $31.35
- Year Low
- $3.25
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.51
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
62
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
7
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 3.41M
ALMS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ALMS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Pangali Sanam | officer: Chief Legal Officer | 2026-07-06 | M-Exempt | 5.06 | 2026-07-08 |
| Pangali Sanam | officer: Chief Legal Officer | 2026-07-06 | M-Exempt | 5.06 | 2026-07-08 |
| Pangali Sanam | officer: Chief Legal Officer | 2026-07-06 | S-Sale | 28 | 2026-07-08 |
| TETRAULT LYNN A. | director | 2026-06-30 | A-Award | 28.14 | 2026-07-02 |
| TETRAULT LYNN A. | director | 2026-06-30 | A-Award | 0 | 2026-07-02 |
| Yao Zhengbin | director | 2026-06-30 | A-Award | 0 | 2026-07-02 |
| Yao Zhengbin | director | 2026-06-30 | A-Award | 28.14 | 2026-07-02 |
| Srivastava Sapna | director | 2026-06-30 | A-Award | 28.14 | 2026-07-02 |
| Srivastava Sapna | director | 2026-06-30 | A-Award | 0 | 2026-07-02 |
| Machado Patrick | director | 2026-06-30 | A-Award | 28.14 | 2026-07-02 |
| Machado Patrick | director | 2026-06-30 | A-Award | 0 | 2026-07-02 |
| AKKARAJU SRINIVAS | director | 2026-06-30 | A-Award | 28.14 | 2026-07-02 |
| AKKARAJU SRINIVAS | director | 2026-06-30 | A-Award | 0 | 2026-07-02 |
| Drappa Jorn | officer: Chief Medical Officer | 2026-05-22 | M-Exempt | 5.06 | 2026-05-27 |
| Drappa Jorn | officer: Chief Medical Officer | 2026-05-22 | M-Exempt | 8.84 | 2026-05-27 |
| Drappa Jorn | officer: Chief Medical Officer | 2026-05-22 | M-Exempt | 5.06 | 2026-05-27 |
| Drappa Jorn | officer: Chief Medical Officer | 2026-05-22 | M-Exempt | 8.84 | 2026-05-27 |
| Foresite Labs, LLC | 10 percent owner | 2026-04-01 | J-Other | 0 | 2026-04-03 |
| Foresite Labs, LLC | 10 percent owner | 2026-04-01 | J-Other | 0 | 2026-04-03 |
| Foresite Labs, LLC | 10 percent owner | 2026-04-01 | J-Other | 0 | 2026-04-03 |
| Foresite Capital Management VI LLC | 10 percent owner | 2026-04-01 | J-Other | 0 | 2026-04-03 |
| Foresite Capital Management VI LLC | 10 percent owner | 2026-04-01 | J-Other | 0 | 2026-04-03 |
| Foresite Capital Management VI LLC | 10 percent owner | 2026-04-01 | J-Other | 0 | 2026-04-03 |
| Tananbaum James B. | director, 10 percent owner: | 2026-04-01 | J-Other | 0 | 2026-04-03 |
| Tananbaum James B. | director, 10 percent owner: | 2026-04-01 | J-Other | 0 | 2026-04-03 |
| Tananbaum James B. | director, 10 percent owner: | 2026-04-01 | J-Other | 0 | 2026-04-03 |
| Goldstein David M | officer: Chief Scientific Officer | 2025-12-31 | 0 | 2026-02-11 | |
| Goldstein David M | officer: Chief Scientific Officer | 2025-12-31 | 0 | 2026-02-11 | |
| Goldstein David M | officer: Chief Scientific Officer | 2025-12-31 | 0 | 2026-02-11 | |
| Pangali Sanam | officer: Chief Legal Officer | 2026-01-26 | A-Award | 26.31 | 2026-01-28 |
| Babler Martin | director, officer: President, CEO and Chairman | 2026-01-26 | A-Award | 26.31 | 2026-01-28 |
| Hardiman Roy C. | officer: Chief Business & Strategy Ofcr | 2026-01-26 | A-Award | 26.31 | 2026-01-28 |
| Bradley Mark Christopher | officer: Chief Development Officer | 2026-01-26 | A-Award | 26.31 | 2026-01-28 |
| Drappa Jorn | officer: Chief Medical Officer | 2026-01-26 | A-Award | 26.31 | 2026-01-28 |
| Schroer John R. | officer: Chief Financial Officer | 2026-01-26 | A-Award | 26.31 | 2026-01-28 |
| Goldstein David M | officer: Chief Scientific Officer | 2026-01-26 | A-Award | 26.31 | 2026-01-28 |
| AKKARAJU SRINIVAS | director | 2026-01-09 | P-Purchase | 17 | 2026-01-13 |
| Foresite Labs, LLC | 10 percent owner | 2026-01-08 | P-Purchase | 17 | 2026-01-12 |
| Foresite Labs, LLC | 10 percent owner | 2026-01-08 | P-Purchase | 17 | 2026-01-12 |
| Foresite Capital Management VI LLC | 10 percent owner | 2026-01-08 | P-Purchase | 17 | 2026-01-12 |
| Foresite Capital Management VI LLC | 10 percent owner | 2026-01-08 | P-Purchase | 17 | 2026-01-12 |
| Tananbaum James B. | director, 10 percent owner: | 2026-01-08 | P-Purchase | 17 | 2026-01-12 |
| Tananbaum James B. | director, 10 percent owner: | 2026-01-08 | P-Purchase | 17 | 2026-01-12 |
| AKKARAJU SRINIVAS | director | 2025-12-05 | P-Purchase | 10.73 | 2025-12-09 |
| AKKARAJU SRINIVAS | director | 2025-12-05 | P-Purchase | 10.01 | 2025-12-09 |
| AKKARAJU SRINIVAS | director | 2025-12-05 | P-Purchase | 8.95 | 2025-12-09 |
| AKKARAJU SRINIVAS | director | 2025-12-04 | P-Purchase | 8.18 | 2025-12-04 |
| AKKARAJU SRINIVAS | director | 2025-12-03 | P-Purchase | 7.75 | 2025-12-04 |
| AKKARAJU SRINIVAS | director | 2025-12-02 | P-Purchase | 7.55 | 2025-12-04 |
| AKKARAJU SRINIVAS | director | 2025-12-01 | P-Purchase | 7.46 | 2025-12-01 |
| AKKARAJU SRINIVAS | director | 2025-11-28 | P-Purchase | 7.64 | 2025-12-01 |
| AKKARAJU SRINIVAS | director | 2025-11-26 | P-Purchase | 7.64 | 2025-12-01 |
| Foresite Capital Management VI LLC | 10 percent owner | 2025-11-21 | P-Purchase | 7.38 | 2025-11-25 |
| Tananbaum James B. | director, 10 percent owner: | 2025-11-21 | P-Purchase | 7.38 | 2025-11-25 |
| Foresite Labs, LLC | 10 percent owner | 2025-11-21 | P-Purchase | 7.38 | 2025-11-25 |
| AKKARAJU SRINIVAS | director | 2025-11-20 | P-Purchase | 7.2 | 2025-11-24 |
| Foresite Labs, LLC | 10 percent owner | 2025-11-19 | P-Purchase | 6.56 | 2025-11-19 |
| Foresite Labs, LLC | 10 percent owner | 2025-11-18 | P-Purchase | 6.19 | 2025-11-19 |
| Foresite Labs, LLC | 10 percent owner | 2025-11-17 | P-Purchase | 5.59 | 2025-11-19 |
| Foresite Labs, LLC | 10 percent owner | 2025-11-17 | P-Purchase | 5.6 | 2025-11-19 |
| Foresite Capital Management VI LLC | 10 percent owner | 2025-11-19 | P-Purchase | 6.56 | 2025-11-19 |
| Foresite Capital Management VI LLC | 10 percent owner | 2025-11-18 | P-Purchase | 6.19 | 2025-11-19 |
| Foresite Capital Management VI LLC | 10 percent owner | 2025-11-17 | P-Purchase | 5.59 | 2025-11-19 |
| Foresite Capital Management VI LLC | 10 percent owner | 2025-11-17 | P-Purchase | 5.6 | 2025-11-19 |
| Tananbaum James B. | director, 10 percent owner: | 2025-11-19 | P-Purchase | 6.56 | 2025-11-19 |
| Tananbaum James B. | director, 10 percent owner: | 2025-11-18 | P-Purchase | 6.19 | 2025-11-19 |
| Tananbaum James B. | director, 10 percent owner: | 2025-11-17 | P-Purchase | 5.59 | 2025-11-19 |
| Tananbaum James B. | director, 10 percent owner: | 2025-11-17 | P-Purchase | 5.6 | 2025-11-19 |
| AKKARAJU SRINIVAS | director | 2025-11-19 | P-Purchase | 6.56 | 2025-11-19 |
| AKKARAJU SRINIVAS | director | 2025-11-18 | P-Purchase | 6.05 | 2025-11-19 |
| AKKARAJU SRINIVAS | director | 2025-11-17 | P-Purchase | 5.51 | 2025-11-19 |
| AKKARAJU SRINIVAS | director | 2025-11-13 | P-Purchase | 5.25 | 2025-11-17 |
| TETRAULT LYNN A. | director | 2025-07-30 | A-Award | 4.1 | 2025-08-01 |
| Yao Zhengbin | director | 2025-07-30 | A-Award | 4.1 | 2025-08-01 |
| Srivastava Sapna | director | 2025-07-30 | A-Award | 4.1 | 2025-08-01 |
| Machado Patrick | director | 2025-07-30 | A-Award | 4.1 | 2025-08-01 |
| AKKARAJU SRINIVAS | director | 2025-07-30 | A-Award | 4.1 | 2025-08-01 |
| Pangali Sanam | officer: Chief Legal Officer | 2025-07-29 | A-Award | 3.95 | 2025-07-31 |
| Pangali Sanam | officer: Chief Legal Officer | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Richardson Derrick | officer: SVP, People and Culture | 2025-07-29 | A-Award | 3.95 | 2025-07-31 |
| Richardson Derrick | officer: SVP, People and Culture | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Schroer John R. | officer: Chief Financial Officer | 2025-07-29 | A-Award | 3.95 | 2025-07-31 |
| Schroer John R. | officer: Chief Financial Officer | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Hardiman Roy C. | officer: Chief Business & Strategy Ofcr | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Hardiman Roy C. | officer: Chief Business & Strategy Ofcr | 2025-07-29 | A-Award | 3.95 | 2025-07-31 |
| Goldstein David M | officer: Chief Scientific Officer | 2025-07-29 | A-Award | 3.95 | 2025-07-31 |
| Goldstein David M | officer: Chief Scientific Officer | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Drappa Jorn | officer: Chief Medical Officer | 2025-07-29 | A-Award | 3.95 | 2025-07-31 |
| Drappa Jorn | officer: Chief Medical Officer | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Bradley Mark Christopher | officer: Chief Development Officer | 2025-07-29 | A-Award | 3.95 | 2025-07-31 |
| Bradley Mark Christopher | officer: Chief Development Officer | 2025-07-29 | A-Award | 0 | 2025-07-31 |
| Babler Martin | director, officer: President, CEO and Chairman | 2025-07-29 | A-Award | 3.95 | 2025-07-31 |
| Babler Martin | director, officer: President, CEO and Chairman | 2025-07-29 | A-Award | 3.95 | 2025-07-31 |
| Pangali Sanam | officer: Chief Legal Officer | 2025-07-10 | A-Award | 3.56 | 2025-07-14 |
| Pangali Sanam | officer: Chief Legal Officer | 2025-07-04 | 0 | 2025-07-14 | |
| Pangali Sanam | officer: Chief Legal Officer | 2025-07-04 | 10.29 | 2025-07-14 | |
| Pangali Sanam | officer: Chief Legal Officer | 2025-07-04 | 5.06 | 2025-07-14 | |
| AKKARAJU SRINIVAS | director | 2025-05-21 | A-Award | 0 | 2025-05-23 |
| AyurMaya Capital Management Company, LP | director, 10 percent owner, other: See Remarks | 2025-05-21 | A-Award | 0 | 2025-05-23 |
| Machado Patrick | director | 2025-05-21 | A-Award | 9.26 | 2025-05-23 |